MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 238 filers reported holding MIRATI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,079,390 | +164923.9% | 109,720 | +101.1% | 0.01% | +30.0% |
| Q4 2022 | $2,472 | -99.9% | 54,550 | +104.1% | 0.01% | +25.0% |
| Q3 2022 | $1,874,000 | -90.4% | 26,723 | -90.3% | 0.01% | -76.5% |
| Q2 2022 | $19,486,000 | +934.3% | 275,280 | +1149.1% | 0.03% | +466.7% |
| Q1 2022 | $1,884,000 | +144.7% | 22,039 | +389.8% | 0.01% | +200.0% |
| Q1 2021 | $770,000 | +190.6% | 4,500 | +273.1% | 0.00% | – |
| Q4 2020 | $265,000 | -15.3% | 1,206 | -36.1% | 0.00% | -100.0% |
| Q3 2020 | $313,000 | -21.6% | 1,887 | -46.1% | 0.00% | 0.0% |
| Q2 2020 | $399,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |